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Objectives. To analyze the effects of a long-term intensive lifestyle intervention including high-intensity inter-
val training (HIIT) andMediterranean diet (MedD) counseling on glycemic control parameters, insulin resistance
and β-cell function in obese subjects.
Methods. The glycemic control parameters (fasting plasma glucose, glycated hemoglobin), insulin resistance,
and β-cell function of 72 obese subjects (54 women; mean age = 53 ± 9 years) were assessed at baseline and
upon completion of a 9-month intensive lifestyle intervention program conducted at the cardiovascular preven-
tion and rehabilitation center of the Montreal Heart Institute, from 2009 to 2012. The program included 2–3
weekly supervised exercise training sessions (HIIT and resistance exercise), combined to MedD counseling.
Results. Fasting plasmaglucose (FPG) (mmol/L) (before: 5.5±0.9; after: 5.2±0.6; P b 0.0001), fasting insulin
(pmol/L) (before: 98± 57; after: 82 ± 43; P= 0.003), and insulin resistance, as assessed by the HOMA-IR score
(before: 3.6 ± 2.5; after: 2.8 ± 1.6; P= 0.0008) signiﬁcantly improved, but not HbA1c (%) (before: 5.72± 0.55;
after: 5.69 ± 0.39; P = 0.448), nor β-cell function (HOMA-β, %) (before: 149 ± 78; after: 144 ± 75; P = 0.58).
Conclusion. Following a 9-month intensive lifestyle intervention combining HIIT andMedD counseling, obese
subjects experienced signiﬁcant improvements of FPG and insulin resistance. This is the ﬁrst study to expose the
effects of a long-term program combining HIIT andMedD on glycemic control parameters among obese subjects.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Lifestyle modiﬁcations refer to an integrated non-pharmacological
approach aiming to reduce traditional cardiovascular risk factors. Cur-
rent practice guidelines recommend integrated lifestyle modiﬁcations
including weight control, exercise training, and nutritional modiﬁca-
tions to improve cardiovascular risk factors and to promote health
(Eckel et al., 2014;Haskell et al., 2007). Clinical research has so farmain-
ly focused on the single components of lifestyle interventions (diet,ng plasma glucose; HIIT, high-
ia; MedD, Mediterranean diet;
e training.
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. This is an open access article underexercise) to assess their respective effects on health (Estruch et al.,
2013; Manson et al., 2002), despite the fact that they are recommended
in combination (Eckel et al., 2014; Haskell et al., 2007). More recently,
however, few randomized trials have tested them in combination
(Fernandez et al., 2012; Group, T.L.A.R., 2013; Landaeta-Díaz et al.,
2013).
Mediterranean diet (MedD) alone has been shown to reduce the
incidence of major cardiovascular events and to be very effective in
the reduction and long-termmaintenance of bodymass, blood pressure,
and cholesterol levels in obese subjects with high cardiovascular risk
(Estruch et al., 2013; Shai et al., 2008). High-intensity interval training
(HIIT) involves bouts of exercise at an intensity close to 90–100% of
VO2max, interspersed with periods of active or passive recovery. The
advised exercise modality in the most recent guidelines is generally
moderate-to-vigorous intensity continuous exercise training (MICET),
(Donnelly et al., 2009; Eckel et al., 2014; Haskell et al., 2007; Jensen
et al., 2014) and very little details regarding HIIT protocols available
are provided (Eckel et al., 2014; Haskell et al., 2007). Previous studies
demonstrated that HIIT was more efﬁcient to improve body compo-
sition, blood pressure, lipid composition, and VO2peak than MICETthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Baseline characteristics of the obese subjects.
Age (years) (mean ± SD) 53 ± 9
Gender (female/male) (54/18)
Body mass (kg) (mean ± SD) 97 ± 18
Body mass index (kg/m2) (mean ± SD) 35.3 ± 5.3
Waist circumference (cm) (mean ± SD) 111 ± 13
Total fat mass (kg) (mean ± SD) 41 ± 11
Trunk fat mass (kg) (mean ± SD) 21 ± 5
Diabetes 7 (10%)
Hypertension 22 (31%)
Current smoking 4 (6%)
Dyslipidemia 26 (36%)
VO2peak (METs) (mean ± SD) 8.6 ± 1.6
Total cholesterol (mmol/L) (mean ± SD) 5.0 ± 1.1
LDL-cholesterol (mmol/L) (mean ± SD) 3.0 ± 1.0
HDL-cholesterol (mmol/L) (mean ± SD) 1.4 ± 0.3
Triglycerides (mmol/L) (mean ± SD) 1.4 ± 0.7
Medication
Antiplatelet agents 14 (19%)
Beta-blockers 5 (6.9%)
Calcium channel blockers 6 (8.3%)
ACE inhibitors 7 (9.7%)
Angiotensin receptor blocker 16 (22%)
Statins 20 (27%)
Oral antidiabetic 3 (4%)
Parenteral insulin 0 (0%)
FPG: fasting plasmaglucose; HOMA-IR: HomeostasisModel Assessment for insulin resis-
tance; SD: standard-deviation.
Study conducted at the EPIC Center of the Montreal Heart Institute (2009–2012).
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et al., 2008). In addition, short-term studies (12 weeks) have shown
that MedD combined with HIIT was superior to MedD alone to improve
ﬁtness, body composition, circulating endothelial progenitors, and
health-related quality of life (Fernandez et al., 2012; Landaeta-Díaz
et al., 2013), indicating a cumulative effect of both nutritional and exer-
cise interventions.
Even amongnon-diabetic subjects, glycated hemoglobin (HbA1c) is a
strong predictor of hard coronary events in the general population (Pai
et al., 2013), which makes glycemic control parameters interesting
targets in primary prevention. Previous short-term randomized trials
studies (12 to 16 week follow-ups) comparing HIIT vs. MICET have
demonstrated either similar improvements of glycemic control param-
eters (fasting glycemia and insulin resistance), (Mitranun et al., 2014;
Nybo et al., 2010) or superiority of HIIT for improvements of glycemic
control parameters in overweight/obese patients (Mitranun et al.,
2014; Tjønna et al., 2008). The effects of a long-term combination of
HIIT with MedD on glycemic parameters are currently not documented
in obese patients.
The ﬁrst objective of this study was to assess the cumulative effects
of HIIT and MedD in a long-term (9 months) lifestyle intervention pro-
gramonglycemic control parameters, insulin resistance andβ-cell func-
tion in obese subjects. The second objective was to describe the effects
of this program on the same parameters in obese subjects according
to their initial glycemic and insulin sensitivity statuses (diabetes, im-
paired fasting glycemia [IFG] or normal glycemia; insulin sensitive or
resistant).
Methods
A retrospective study was performed at the Cardiovascular Preven-
tion and Rehabilitation Center (ÉPIC) of the Montreal Heart Institute.
Data from patients undergoing a 9-month clinical intensive lifestyle
modiﬁcation program (2009–2012), involving supervised HIIT training
andMedD nutrition counseling, were retrospectively analyzed. Accord-
ing to the Institutional Review Board policy of the Montreal Heart Insti-
tute concerning retrospective studies, the present study was approved
by the Ethical Committee of the Montreal Heart Institute.
Study population
Inclusion criteria at baselinewere age over 18 years, and obesity de-
ﬁned as: 1) waist circumference ≥80 cm for women, ≥94 cm for men
and 2) fat mass percentage N25% in men and N35% in women (Cornier
et al., 2011). Detailed inclusion and exclusion criteria are provided in
the Supplementary Methods section.
Exercise training program
Supervised exercise training sessions consisted of 2 to 3 supervised
60-min weekly sessions of HIIT (combined with resistance training).
HIIT prescription was based upon the results of the baseline maximal
treadmill exercise test and estimated maximal aerobic power. HIIT ses-
sions were performed on ergocycle (Precor, model 846i, USA) under
supervision of a kinesiologist and consisted of a 5-min warm-up at
50 W, followed by two sets of 10 min of repeated bouts of 15 to 30 s
at 80% of maximal aerobic power interspersed by 15 to 30 s periods of
passive recovery, and a 5-min cool down at 50W. The targeted Borg rat-
ing of perceived exertion (RPE) was set at 15 during the exercise ses-
sions. The two 10-min periods were separated by a 4-min passive
recovery. Total exercise time was 34 min per HIIT session. Resistance
training was prescribed and performed under supervision of a kinesiol-
ogist, and consisted of 20min of circuit weight training performed with
free weights and elastic bands adapted to each patient's capacity. For
each muscle group, patients performed 1 set of 15 to 20 repetitions,
followed by a 30-s rest period, at a target RPE of 15. Subjects wereencouraged to perform 1 or 2 additional unsupervised continuous
moderate intensity sessions per week, such as walking and/or cycling
(45-min duration, Borg scale level averaging 12–14) outside or inside
the center.Nutritional counseling intervention
All subjects underwent 5 individual meetings with a dietician in our
center. The ﬁrst visit was used to obtain data on eating habits andmoti-
vation, and to provide the principles of the MedD. Details of the nutri-
tional counseling are exposed in the Supplementary Methods section.Statistical analysis
Statistical analysis was performed with SPSS® Statistics 20.0 (IBM®,
Armonk, NY). Continuous variables are expressed as mean± standard-
deviation. Categorical variables are expressed as frequencies (percent-
age). For continuous variables, statistical differences in all subjects
were evaluated by an ANOVAwith repeated measure (time). Statistical
differences in the sub-groups of obese subjects (insulin resistant and
sensitive; diabetics, IFG and normal fasting plasma glucose [FPG])
were evaluated by a 2 way ANOVA (group and program). A post hoc
test (Bonferroni) with a P value ≤ 0.05 was used to localize differences.
Insulin resistance was deﬁned as an HOMA-IR score ≥2.6 (Ascaso et al.,
2003).Results
Baseline characteristics
Baseline characteristics are shown in Table 1. Seventy-two obese
subjects were included, from 2009 to 2012. Forty-three subjects (59%)
had a normal FPG (b5.6 mmol/L), twenty-two subjects (30%) had
an IFG (FPG: 5.6–6.9 mmol/L) and seven subjects were diabetics
(FPG ≥7.0 mmol/L). Insulin resistance (HOMA-IR ≥2.6) was present in
41 subjects (57%).
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After the program, 2 subjects were diabetics (reduction of 5 subjects
or 7%; P=0.08), 15 subjects had an IFG (reduction of 7 subjects or 9.7%;
P= 0.18) and 55 subjects had a normal fasting glycemia (increase of 12
subjects or+16.6%; P=0.03). After the program, insulin resistancewas
present in 32 subjects (44%) indicating a reduction in 12 patients
(−13%) (P = 0.06). Glycemic control and insulin parameters for all
obese subjects are presented in Table 2.
Glycemic control and insulin parameters for insulin resistant
and insulin sensitive obese subjects are presented in Table 3. At
baseline, glycemic and insulin parameters (FPG, HbA1c, fasting insulin,
HOMA-IR), and beta-cell function (HOMA-β) were higher in insulin
resistant obese subjects (P b 0.001). After the program, FPG, fasting
insulin and insulin resistance (HOMA-IR) were signiﬁcantly improved
only in insulin resistant obese subjects, and no improvement was seen
for insulin sensitive obese subjects.
Body composition, blood pressure and exercise parameters
Improvements of body composition, blood pressure and exercise pa-
rameters are provided in supplementary materials (Tables S1 to S4).
Discussion
In our study, we report the effects of a long-term intensive lifestyle
intervention program, including HIIT and MedD counseling, on glyce-
mic control parameters in obese subjects. Our results show that an im-
provement of the FPG, fasting insulin, and HOMA-IR occurs upon
completion of the program, but only for obese subjectswith baseline in-
sulin resistance. These results highlight a possible role for this combined
lifestyle intervention in the improvement of risk factors of cardiovascu-
lar diseases in the obese population.
The combination of MedD and HIIT have only been studied by one
group so far, in a 12 week program involving 45 patients (Fernandez
et al., 2012; Landaeta-Díaz et al., 2013). They showed that compared
toMedD alone, the combination improves the levels of circulating of en-
dothelial progenitor cells, cardiorespiratory ﬁtness, cardiovascular risk
factors, and health-related quality of life. To date, no study aimed to
identify the effects of this combination on the glycemic control param-
eters and insulin resistance as a primary objective. Additionally, no re-
port of the long-term effects of this combination on health-related
parameters has been published. Our study thus constitutes the second
report of the effects of this combination on health parameters, and the
ﬁrst onewith a relatively long-termprogram (9months). In the context
of the endemic state of obesity in Western countries, these results are
relevant in a public health perspective, given that an obese phenotype,
independently of the other cardiovascular risk factors, increases the
risks of cardiovascular diseases, CAD, death from CAD, congestive
heart failure, and diabetes (Hubert et al., 1983; Wilson et al., 2007).
The Look AHEAD investigators previously showed that among
overweight-to-obese diabetic patients, a an intensive lifestyle interven-
tion including a caloric-restriction diet and regular MICET, with the aimTable 2
Glycemic control, insulin parameters and β-cell function in all obese subjects before and
after the program.
All subjects (n = 72) Before After Δ ANOVA P-value
FPG (mmol/L) 5.5 ± 0.9 5.2 ± 0.6 −0.31 ± 0.64 b0.0001
HbA1c (%) 5.72 ± 0.55 5.69 ± 0.39 −0.03 ± 0.34 0.448
Insulin (pmol/L) 98 ± 57 82 ± 43 −16 ± 44 0.003
HOMA-IR 3.6 ± 2.5 2.8 ± 1.6 −0.8 ± 2.0 0.0008
HOMA-β (%) 149 ± 78 144 ± 75 −5 ± 71 0.58
FPG: fasting plasma glucose, HOMA-β: HomeostasisModel Assessment forβ-cell function,
HOMA-IR: Homeostasis Model Assessment for insulin resistance.
Study conducted at the EPIC Center of the Montreal Heart Institute (2009–2012).of a 7%weight loss or more, is associated with a modest increase in par-
tial remission of diabetes (Gregg et al., 2012), and an improvement of
health-related quality of life (Williamson et al., 2009). More recently,
however, they failed to show an improvement of major cardiovascular
events rates (compared to the control group) after a median follow-
up of 9.6 years (Group, T.L.A.R., 2013). However, by the time this trial
was initiated, the beneﬁts of the MedD and HIIT were not as well
established compared to other modes of nutritional and exercise train-
ing, respectively.
It has recently been shown in a randomized trial that a MedD adds a
protection against major cardiovascular events in high-risk patients
without known cardiovascular disease compared to a control low-fat
diet.(Estruch et al., 2013) MedD improves fasting plasma glucose and
insulin resistance compared to a low-fat, restricted-calorie diet in
diabetic patients.(Shai et al., 2008) However, it is not associated with
signiﬁcant improvements of fasting plasma glucose and insulin sensitiv-
ity in non-diabetic subjects.(Shai et al., 2008) Complementary lifestyle
interventions, such as exercise training, should thus be encouraged to
address the improvement of glycemic parameters in non-diabetic pa-
tients, in the objective of reducing coronary events.(Pai et al., 2013) In
the last decade, growing evidence has made HIIT to be considered as a
safe and effective alternative to MICE in a variety of settings. It has a
better tolerability proﬁle, and improves further peak VO2 (Gayda
et al., 2012; Guiraud et al., 2011; Meyer et al., 2010; Rognmo et al.,
2004; Weston et al., 2014). Short-term HIIT programs have been
assessed in very small cohorts, and have been shown to improve glyce-
mic control parameters.(Adams, 2013) However, the beneﬁts of a long-
termHIIT program in the improvement of glycemic control in obese pa-
tients has only scarcely been studied.(Tjønna et al., 2008) This drove the
rationale for out observational study.
It could be hypothesized that designing a study similar to the Look
AHEAD trial, but involving HIIT and MedD instead of MICET and a
caloric-restriction diet, might improve cardiovascular outcomes, but it
should be investigated.(Group, T.L.A.R., 2013) The results of our study
and of others (Fernandez et al., 2012; Gregg et al., 2012; Landaeta-
Díaz et al., 2013; Pai et al., 2013) could constitute a rationale for design-
ing a randomized controlled trial analyzing the effects of a combination
of HIIT and MedD on glycemic control parameters and cardiovascular
clinical outcomes.Limitations and strengths
The main limitation of our study, explained by its retrospective na-
ture, is the absence of comparative assessment of the combination of
MedDandHIIT to groups of patients undergoing different lifestyle inter-
ventions. It hinders any attempt to extrapolate the superiority of this
speciﬁc combination of lifestyle intervention over another lifestyle in-
tervention, a shortcoming we are fully conscious about. The aim was
however to provide relevant exploratory hypothesis-generating data
by testing this speciﬁc combination of lifestyle interventions. The effects
of a long-term program involving the combination of MedD and HIIT on
glycemic control parameters in obese patients have never been investi-
gated before. It is of clinical value to know if beneﬁts can be sustained
over a long period, particularly with obese subjects. Many examples in
the primary prevention literature have shown that short-term beneﬁts
of lifestyle interventions are not sustained in the long-term. In addition,
the effects of this longer-term combined intervention on glycemic con-
trol and insulin resistance status has never been studied. It is of great
clinical value to know if patients with different glycemic and/or insulin
resistance statuses respond similarly or differently to this combined
long-term intervention, and this is the main originality of this work.
Given the scarcity of studies assessing an integrated lifestyle modiﬁ-
cation approach on health-related endpoints, even though lifestyle
modiﬁcations are recommended in combination in guidelines, our
study could contribute to provide hypothesis-generating data on the
Table 3
Glycemic control, insulin parameters and β-cell function in insulin sensitive and resistant obese subjects before and after the program.
Insulin sensitive (n = 31) Insulin resistant (n = 41) P value
Before After Δ Before After Δ
FPG (mmol/L) 5.0 ± 0.5 4.9 ± 0.4 −0.1 ± 0.4 6.0 ± 1.0 5.5 ± 0.7⁎⁎ −0.5 ± 0.7 a b 0.0001
b = 0.020
c = 0.101
HbA1c (%) 5.43 ± 0.30 5.48 ± 0.27 +0.07 ± 0.28 5.94 ± 0.60 5.76 ± 0.42 −0.11 ± 037 a b 0.0001
b = 0.394
c = 0.130
Insulin (pmol/L) 54 ± 14 58 ± 22 +4 ± 21 132 ± 54 100 ± 46⁎ −31 ± 50 a b 0.0001
b = 0.045
c = 0.008
HOMA-IR 1.7 ± 0.4 1.8 ± 0.8 +0.1 ± 0.7 5.1 ± 2.5 3.5 ± 1.6⁎ −1.57 ± 2.38 a b 0.0001
b = 0.010
c = 0.002
HOMA-β (%) 120 ± 76 129 ± 63 +8 ± 74 171 ± 74 156 ± 82 −15 ± 68 a = 0.002
b = 0.805
c = 0.361
FPG, fasting plasma glucose; HOMA-β, HomeostasisModel Assessment for β-cell function; HOMA-IR, HomeostasisModel Assessment for insulin resistance. a= group effect, b=program
effect, c = interaction effect (group × program).
Insulin resistance was deﬁned by a HOMA-IR ≥2.6. a = group effect, b = program effect, c = interaction effect (group × program).
Study conducted at the EPIC Center of the Montreal Heart Institute (2009–2012).
⁎ Before vs. after post hoc Bonferroni test: P b 0.001.
⁎⁎ Before vs. after post hoc Bonferroni test: P b 0.0001.
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future outcome-oriented prospective trials on this topic.
Another limitation is that our study includes a relatively low sample
size, and may not have been powered enough to detect improvements
of HbA1c.
The external validity of our study is limited by three main elements.
First, the enrolment in the program was not free for the subjects, thus
our data can only be extrapolated to people in the population who can
afford to pay for a lifestyle intervention, who may carry a different car-
diovascular risk burden proﬁle compared to the general population.
Second, the enrolment in the program requires a certain degree of mo-
tivation, given that recruitment was made on a self-initiative basis. This
limitation, however, applies to the majority of lifestyle intervention
studies, given that non-motivated subjects usually do not enroll in
such trials, and this shortcoming does not thwart the scope of our ﬁnd-
ings. Third, the exclusion of subjectswhodid not complete the program,
forwhomwe did not have theﬁnal data on the glycemic control param-
eters, causes a selection bias.
We used a surrogatemarker of insulin resistance (HOMA-IR) instead
of a direct measure with an oral glucose tolerance test (OGTT). This
study used data from a clinical program not originally designed for re-
search purposes, which explains the lack of systematic measures of
OGTT upon inclusion of the patients. Also, no adherence data for the
MedD is available, but the purpose of the study was to assess the effects
of a program on an intent-to-treat basis.
The originality of our study resides in the fact that we analyzed a
long-term program, compared to previous attempts to assess the effects
of HIIT on glycemic control parameters, that a combined lifestyle
intervention was used, and that the glycemic control parameters im-
provements have never been assessed previously following such inter-
vention in obese subjects.Conclusion
In conclusion, we showed that a 9-month intensive lifestyle inter-
vention including HIIT and MedD improves FPG, fasting insulin, and in-
sulin sensitivity, particularly among insulin resistant obese subjects. Our
data suggest that these lifestyle interventionsmight improve cardiovas-
cular risk factors in obese subjects, and calls for the implementation of a
randomized trial analyzing the combination of HITT and MedD on hard
cardiovascular endpoints.Conﬂict of interest
The authors declare that there are no conﬂicts of interest.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.pmedr.2015.04.015.
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